期刊文献+

巨大左室二尖瓣机械瓣置换术后远期随访 被引量:1

LONG TERM CLINICAL RESULTS OF MECHANICAL HEART VALVE REPLACEMENT FOR MITRAL VALVE DISEASE WITH LARGE LEFT VENTRICLE
下载PDF
导出
摘要 目的分析探讨巨大左心室机械瓣置换术后的远期疗效。方法1982年5月~2003年4月,我院为148例左心室舒张末径(LVDD)>70mm的患者实施二尖瓣机械瓣置换手术。其中男123例,女25例。平均年龄38.26±12.37岁。随访136例,总随访率97.89%,随访平均人年计6.12年。结果远期死亡21例,5、10、15年生存率为90.31%、80.27%、72.62%。术后心功能、LVDD、左室射血分数(LVEF)与术前比较明显改善(P<0.05)。结论巨大左心室二尖瓣机械瓣置换术远期疗效满意,术前LVDD、LVEF、术中二尖瓣瓣下结构的保留和三尖瓣成形术是影响术后远期疗效的主要因素。 Objective To analyze the long-term clinical result of mechanical heart valve replacement for Mitral valve disease with large left ventricle. Methods Between May,1982 and April, 2003, mechanical heart valve prostheses replacements were performed in 148 patients with left ventricular end-diastolic diameter large than 70mm(123 males, 25 females). The mean age was (38.26±12.37) year-old. 136 patients(97.14%) were followed-up for and average time of 6.12 patient-years. Results 21 patients died during the follow-up period. The survival rates at 5, 10 and 15 years were 90.20%, 80.43% and 71.62%, respectively. The heart functional status improved significantly, especially in left ventricular end-diastolic diameter (LVDD) and left ventricular ejection fraction(LVEF). Conclusion Artificial mechanical heart valve replacement are rather effectively for Mitral valve disease with large left ventricle, preoperative LVDD and LVEF, subvalvular structure preservation and tricuspid annuloplasty were major factors that effected long-term result.
出处 《中国心血管病研究》 CAS 2005年第2期138-140,共3页 Chinese Journal of Cardiovascular Research
关键词 心脏瓣膜假体植入 机械瓣 巨大左心室 随访研究 heart valve prosthesis implantation mechanical valve ventriomegaly left follow-up studies
  • 相关文献

参考文献5

二级参考文献25

  • 1韩涛,陈同,李温仁,张珍治,杨三德,谢维泉,林乌拉,李梅珍.心脏瓣膜置换术后10年随访报告[J].福建医药杂志,1991,0(3):48-48. 被引量:3
  • 2孙衍庆.巨左心房症.现代胸心外科学[M].北京:人民军医出版社,2000.1389-1397.
  • 3Edmunds LH, Clark RE, Cohn LH, etal. Guiddines far mmbidity and mortality after cardiac valvular operation. J Thorac Cardiovaac Surg, 1996,112:708-711.
  • 4Jamieson WR, Edwards FH, Bern JW, et al. Pisk straatificatian for cardiac valve replacement. National Cardiac Surgery Database Committee of The Society of Thoracic Surgeons. Ann Thorac Surg, 1999, 67:943-951.
  • 5Flameng WJ, Herijgers P, Szcsi J, et al. Determinants of early and late resuits of combined valve operations and coronary eatery bypess grafting. Ann Thorac Surg, 1996,61:621 - 628.
  • 6Karp RB, Mills N, Edmunds LH Jr.Coronary artery bypase garfting in the presence of valvular disease. Circulation, 1989,79(6 Pt 2):1182-184.
  • 7van Herwarden LA, Tjan D, Tjissen JG, et al. Determinants of survival after surgery for mitral valve regurgitation in patients with and without coronary artery disease.Eur J Cardiothorac Surg,1990,4:329-335.
  • 8Czer LS, Gray RJ, Stewart ME, eta]. Reduction in sudden late death by concomitant revascularization with acrtic valve replacement, J Thorac Cardiovasc Surg, 1988,95:390-401.
  • 9Magovern JA,Pennock JL,Campbell DB,et al. Aortic valve replacement and combined aortic valve replacement and coronary artery bypess grafting:predicting high risk groups,J Am Coll Cardiol, 1987,9:38-43.
  • 10Loisance DY, Mazzucotelli JP, Bertrand PC, et al. Mitroflow periesrdial valve: long-term durability. Ann Thorac Surg, 1993,56:131 - 136.

共引文献51

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部